Diabetes Clinical Trials in Chicago

Showing 261-280 of 316 trials

A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients

NCT01280695

The purpose of this study is to assess the safety and tolerability of MSDC-0602 and to evaluate the reduction in fasting plasma glucose in patients with Type 2 diabetes.

Diabetes Mellitus, Type 2

Metabolic Solutions Development Company129 participantsStarted Feb 2011

Goodyear, Arizona, United States • Chula Vista, California, United States • Los Angeles, California, United States +11 more locations

COMPLETEDPHASE32.2 miles

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

NCT00996658

The objective of the current study is to investigate the efficacy, safety and tolerability of Linagliptin (5 mg once daily) compared to placebo given for 24 weeks as add on therapy to metformin in combination with pioglitazone in patients with type 2 diabetes mellitus with insufficient glycaemic control.

Diabetes Mellitus, Type 2

Boehringer Ingelheim278 participantsStarted Oct 2009

Escondido, California, United States • Greenbrae, California, United States • Los Angeles, California, United States +49 more locations

A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Diabetes Trials in Other Cities

The Effectiveness of Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk

Chicago Childhood Diabetes Registry

Sleep Disordered Breathing and Diabetes

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Screening for Early Evidence of Diabetes

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Follow-Up Study for Exubera

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Diabetes and Periodontal Therapy Trial

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

Other Conditions in Chicago